ABL1 and acute lymphoblastic leukemia: Furthermore, diagnosing ALL with BCR/ABL1-related genetic abnormalities remains challenging due to genetic heterogeneity and cytogenetic recessive rearrangements, necessitating comprehensive examinations, such as FCM, whole-transcriptome sequencing, fluorescence in situ hybridization, or targeted sequencing methods.